Liyong Pu

2.5k total citations · 1 hit paper
64 papers, 1.7k citations indexed

About

Liyong Pu is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Liyong Pu has authored 64 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 22 papers in Molecular Biology and 20 papers in Immunology. Recurrent topics in Liyong Pu's work include Organ Transplantation Techniques and Outcomes (17 papers), Liver Disease and Transplantation (8 papers) and Immune Cell Function and Interaction (8 papers). Liyong Pu is often cited by papers focused on Organ Transplantation Techniques and Outcomes (17 papers), Liver Disease and Transplantation (8 papers) and Immune Cell Function and Interaction (8 papers). Liyong Pu collaborates with scholars based in China, United States and South Korea. Liyong Pu's co-authors include Xuehao Wang, Jindao Wu, Lianbao Kong, Xiangcheng Li, Liren Zhang, Aihua Yao, Jinhai Tang, Jing Xu, Yong Ni and Beicheng Sun and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Liyong Pu

60 papers receiving 1.7k citations

Hit Papers

HIF-1α-induced expression of m6A reader YTHDF1 drives hyp... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyong Pu China 24 783 457 395 282 274 64 1.7k
Zhuo Lin China 22 731 0.9× 509 1.1× 191 0.5× 124 0.4× 380 1.4× 58 1.4k
Zuojin Liu China 17 434 0.6× 208 0.5× 287 0.7× 325 1.2× 200 0.7× 63 1.3k
Nan You China 19 656 0.8× 410 0.9× 211 0.5× 97 0.3× 212 0.8× 61 1.3k
Qichang Zheng China 19 509 0.7× 255 0.6× 200 0.5× 393 1.4× 199 0.7× 43 1.5k
Liping Zhuang China 21 690 0.9× 617 1.4× 244 0.6× 176 0.6× 223 0.8× 51 1.9k
Margret Rave‐Fränk Germany 25 732 0.9× 343 0.8× 346 0.9× 199 0.7× 125 0.5× 89 1.9k
Sang‐Hyun Song South Korea 26 938 1.2× 187 0.4× 330 0.8× 87 0.3× 241 0.9× 79 1.7k
Qiaoling Pan China 23 604 0.8× 286 0.6× 284 0.7× 158 0.6× 243 0.9× 60 1.3k

Countries citing papers authored by Liyong Pu

Since Specialization
Citations

This map shows the geographic impact of Liyong Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyong Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyong Pu more than expected).

Fields of papers citing papers by Liyong Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyong Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyong Pu. The network helps show where Liyong Pu may publish in the future.

Co-authorship network of co-authors of Liyong Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Liyong Pu. A scholar is included among the top collaborators of Liyong Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyong Pu. Liyong Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yu, et al.. (2025). Targeting Myeloid Trem2 Reprograms the Immunosuppressive Niche and Potentiates Checkpoint Immunotherapy in NASH-Driven Hepatocarcinogenesis. Cancer Immunology Research. 13(10). 1516–1532. 1 indexed citations
2.
Wang, Ziyi, Xuejiao Chen, Jie Li, et al.. (2025). Macrophages Atp6v0d2 regulates XBP1-mediated cholesterol metabolism to suppress metabolic dysfunction-associated steatohepatitis progression. International Immunopharmacology. 161. 115088–115088.
5.
Han, Sheng, Xiangdong Li, Nan Xia, et al.. (2023). Myeloid Trem2 Dynamically Regulates the Induction and Resolution of Hepatic Ischemia-Reperfusion Injury Inflammation. International Journal of Molecular Sciences. 24(7). 6348–6348. 13 indexed citations
6.
Zhang, Yu, Ziyi Wang, Xiangdong Li, et al.. (2023). Blockade of Hepatocyte PCSK9 Ameliorates Hepatic Ischemia-Reperfusion Injury by Promoting Pink1-Parkin–Mediated Mitophagy. Cellular and Molecular Gastroenterology and Hepatology. 17(1). 149–169. 17 indexed citations
7.
Li, Xiangdong, Ziyi Wang, Chenyu Jiao, et al.. (2023). Hepatocyte SGK1 activated by hepatic ischemia-reperfusion promotes the recurrence of liver metastasis via IL-6/STAT3. Journal of Translational Medicine. 21(1). 121–121. 21 indexed citations
8.
Li, Qing, Liren Zhang, Wenhua You, et al.. (2022). PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nature Communications. 13(1). 7677–7677. 61 indexed citations
9.
Chen, Xuejiao, Ziyi Wang, Sheng Han, et al.. (2021). Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment. Cell Death and Disease. 12(12). 1123–1123. 23 indexed citations
10.
Yu, Yue, et al.. (2015). MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma. Biochemical and Biophysical Research Communications. 465(2). 262–269. 29 indexed citations
11.
Xia, Yongxiang, Han Zhuo, Yunjie Lu, et al.. (2015). Glycogen synthase kinase 3β inhibition promotes human iTreg differentiation and suppressive function. Immunologic Research. 62(1). 60–70. 14 indexed citations
12.
Rao, Jianhua, Xiaofeng Qian, Ping Wang, et al.. (2012). All-trans retinoic acid preconditioning protects against liver ischemia/reperfusion injury by inhibiting the nuclear factor kappa B signaling pathway. Journal of Surgical Research. 180(2). e99–e106. 37 indexed citations
13.
Xia, Yongxiang, Ling Lü, Zhengshan Wu, et al.. (2012). Inhibition of GSK-3β ameliorates hepatic ischemia-reperfusion injury through GSK-3β/β-catenin signaling pathway in mice. Hepatobiliary & pancreatic diseases international. 11(3). 278–284. 14 indexed citations
14.
Lu, Ling, Yue Yu, Guoqiang Li, et al.. (2009). CD8+CD103+ regulatory T cells in spontaneous tolerance of liver allografts. International Immunopharmacology. 9(5). 546–548. 26 indexed citations
15.
Jiang, Weiwei, et al.. (2009). Liver transplantation for polycystic liver with massive hepatomegaly: A case report. World Journal of Gastroenterology. 15(40). 5112–5112. 6 indexed citations
16.
Yu, Yue, Ling Lü, Xiaofeng Qian, et al.. (2009). Antifibrotic Effect of Hepatocyte Growth Factor-Expressing Mesenchymal Stem Cells in Small-for-Size Liver Transplant Rats. Stem Cells and Development. 19(6). 903–914. 52 indexed citations
17.
Lu, Ling, Guoqiang Li, Jianhua Rao, et al.. (2009). In vitro induced CD4+CD25+Foxp3+ Tregs attenuate hepatic ischemia–reperfusion injury. International Immunopharmacology. 9(5). 549–552. 39 indexed citations
18.
Song, Jun, Yewei Zhang, Aihua Yao, et al.. (2008). Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transplant International. 21(4). 372–383. 20 indexed citations
19.
Pu, Liyong, Xuehao Wang, Feng Zhang, et al.. (2007). Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4+CD25+ regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Surgery. 142(1). 67–73. 33 indexed citations
20.
Guldan, Georgia S., et al.. (1991). Designing Appropriate Nutrition Education for the Chinese: the Urban and Rural Nutrition Situation in Sichuan. Journal of Tropical Pediatrics. 37(4). 159–165. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026